BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35114510)

  • 1. Is EBV the cause of multiple sclerosis?
    Giovannoni G; Hawkes CH; Lechner-Scott J; Levy M; Yeh EA; Gold J
    Mult Scler Relat Disord; 2022 Feb; 58():103636. PubMed ID: 35114510
    [No Abstract]   [Full Text] [Related]  

  • 2. Epstein-Barr virus and multiple sclerosis.
    Lovett-Racke AE; Racke MK
    Arch Neurol; 2006 Jun; 63(6):810-1. PubMed ID: 16769860
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: no.
    Salzer J; Myhr KM
    Mult Scler; 2013 Nov; 19(13):1692-3. PubMed ID: 24218487
    [No Abstract]   [Full Text] [Related]  

  • 4. Fine specificity of the antibody response to Epstein-Barr nuclear antigen-2 and other Epstein-Barr virus proteins in patients with clinically isolated syndrome: A peptide microarray-based case-control study.
    Schlemm L; Giess RM; Rasche L; Pfuhl C; Wakonig K; Behrens JR; Scheibenbogen C; Bellmann-Strobl J; Paul F; Reimer U; Ruprecht K
    J Neuroimmunol; 2016 Aug; 297():56-62. PubMed ID: 27397076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of genetic variation on the molecular mimicry between Anoctamin-2 and Epstein-Barr virus nuclear antigen 1 in Multiple Sclerosis.
    Sepúlveda N
    Immunol Lett; 2021 Oct; 238():29-31. PubMed ID: 34310987
    [No Abstract]   [Full Text] [Related]  

  • 6. EBV and multiple sclerosis: Setting the research agenda.
    Giovannoni G; Vanderdonckt P; Hartung HP; Lassmann H; Comi G
    Mult Scler Relat Disord; 2022 Nov; 67():104158. PubMed ID: 36116382
    [No Abstract]   [Full Text] [Related]  

  • 7. Epstein-barr virus infection and multiple sclerosis: a review.
    Ascherio A; Munger KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):271-7. PubMed ID: 20369303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probing the association between Multiple Sclerosis and Epstein Barr Virus from a therapeutic perspective.
    Drosu N; Giovannoni G; Pohl D; Hawkes C; Lechner-Scott J; Levy M
    Mult Scler Relat Disord; 2021 Jul; 52():103087. PubMed ID: 34139660
    [No Abstract]   [Full Text] [Related]  

  • 9. Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
    Tschochner M; Leary S; Cooper D; Strautins K; Chopra A; Clark H; Choo L; Dunn D; James I; Carroll WM; Kermode AG; Nolan D
    PLoS One; 2016; 11(2):e0147567. PubMed ID: 26849221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K
    Expert Rev Clin Immunol; 2020 Dec; 16(12):1143-1157. PubMed ID: 33152255
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus, latitude and multiple sclerosis.
    Disanto G; Pakpoor J; Morahan JM; Hall C; Meier UC; Giovannoni G; Ramagopalan SV
    Mult Scler; 2013 Mar; 19(3):362-5. PubMed ID: 22767435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI.
    Farrell RA; Antony D; Wall GR; Clark DA; Fisniku L; Swanton J; Khaleeli Z; Schmierer K; Miller DH; Giovannoni G
    Neurology; 2009 Jul; 73(1):32-8. PubMed ID: 19458321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus and multiple sclerosis.
    Ascherio A; Munch M
    Epidemiology; 2000 Mar; 11(2):220-4. PubMed ID: 11021623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus as a cause of multiple sclerosis: opportunities for prevention and therapy.
    Aloisi F; Giovannoni G; Salvetti M
    Lancet Neurol; 2023 Apr; 22(4):338-349. PubMed ID: 36764322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis.
    Lünemann JD; Edwards N; Muraro PA; Hayashi S; Cohen JI; Münz C; Martin R
    Brain; 2006 Jun; 129(Pt 6):1493-506. PubMed ID: 16569670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and disease activity in multiple sclerosis.
    Buljevac D; van Doornum GJ; Flach HZ; Groen J; Osterhaus AD; Hop W; van Doorn PA; van der Meché FG; Hintzen RQ
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1377-81. PubMed ID: 16170080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up.
    DeLorenze GN; Munger KL; Lennette ET; Orentreich N; Vogelman JH; Ascherio A
    Arch Neurol; 2006 Jun; 63(6):839-44. PubMed ID: 16606758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between Multiple Sclerosis or Neuromyelitis Optica and Epstein-Barr Virus].
    Mori M
    Brain Nerve; 2015 Jul; 67(7):881-90. PubMed ID: 26160816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus candidate genes and multiple sclerosis.
    Claire Simon K; Schmidt H; Loud S; Ascherio A
    Mult Scler Relat Disord; 2015 Jan; 4(1):60-4. PubMed ID: 25787055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus and multiple sclerosis.
    Pohl D
    J Neurol Sci; 2009 Nov; 286(1-2):62-4. PubMed ID: 19361810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.